Daewon Pharmaceutical Co., Ltd. (KRX:003220)
10,720
-90 (-0.83%)
Apr 30, 2026, 3:30 PM KST
-21.92% (1Y)
| Market Cap | 231.70B -19.3% |
| Revenue (ttm) | 605.43B +1.2% |
| Net Income | -1.38B |
| EPS | -87.38 |
| Shares Out | 21.43M |
| PE Ratio | n/a |
| Forward PE | 16.21 |
| Dividend | 250.00 (2.30%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 16,258 |
| Average Volume | 29,561 |
| Open | 10,830 |
| Previous Close | 10,810 |
| Day's Range | 10,660 - 10,830 |
| 52-Week Range | 9,670 - 14,700 |
| Beta | 0.26 |
| RSI | 51.93 |
| Earnings Date | May 15, 2026 |